Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 63 for “"BCMA"”.
-
Development of BCMA-specific engineered T cells targeting multiple myeloma
… those targeting B-cell maturation antigen (BCMA). Among different classes of immunotherapies, T cell-based approaches have progressed the most due to their ability to induce durable responses in patients with advanced drug-resistant blood cancers. Most T cell engineering strategies rely on …
-
Κλινική ανάπτυξη συζευγμένων anti-BCMA μονοκλωνικών αντισωμάτων στο πολλαπλό μυέλωμα
… θεραπευτικής προσέγγισης των συζευγμένων anti-BCMA αντισωμάτων. Το πολλαπλό μυέλωμα εμφανίζεται κατά κύριο λόγω σε άτομα άνω των 65 ετών και εκφράζεται ως η ανεξέλεγκτη παραγωγή αντισωμάτων από τα πλασματοκύτταρα στον μυελό των οστών. Η διάγνωσή του γίνεται με βάση εργαστηριακές εξετάσεις που …
-
Barcode Medication Administration (BCMA) Process Change and Failure Rates: A Retrospective Analysis
Barcode Medication Administration (BCMA) is an approved standard process in the delivery of safe care and preventing medication errors. BCMA utilizes bar-code scanning during medication administration that assists the nurse in verifying and validating the medication. Studies have shown that the …
-
Impact of the Bar Code Medication Administration (BCMA) System on Medication Administration Errors
… such as the Bar Code Medication Administration (BCMA) system, offers new opportunities for reducing MAE. BCMA was developed to improve patient safety, improve documentation of medication administration, decrease medication errors, and capture medication accountability data. The overall goal of …
-
Real world experience of BCMA-directed chimeric antigen T-cell therapy for multiple myeloma
INTRODUCTION: Multiple myeloma (MM) is a disease that results in the production of ineffective immunoglobulins and monoclonal proteins in the blood and urine, leading to insufficient organ function or death. Currently, there is a 5-year survival rate of 47% for patients diagnosed with MM, with a …
-
Antioxidant system remodeling underlies off-target effects of anti BCMA-Targeted Immunotherapy in Multiple Myeloma [Il rimodellamento del sistema antiossidante è alla base degli effetti off-target dell’immunoterapia anti-BCMA nel Mieloma Multiplo]
… anticorpo-farmaco coniugato diretto contro BCMA, ha mostrato efficacia clinica nei pazienti recidivati o refrattari, ma è spesso limitato dallo sviluppo di resistenza e da effetti collaterali off-target. In questo lavoro di tesi è stato adottato un approccio integrato proteomico, …
-
Nurse Cognition in Response to Alert Generation During Bar Code Medication Administration (BCMA): An Examination of Human Factors
… response decisions (decision outputs) during BCMA among a cohort of new graduate nurses and 2) examine the influence of human and environmental factors on BCMA alert generation, cognitive response time, and decision to administer among new graduate nurses over their first year of practice. …
-
Neutralization of BAFF and APRIL with engineered soluble BCMA decoy receptor for the treatment of B-cell malignancies
… extracellular cysteine rich domain (ECD) of the BCMA (B-cell maturation antigen) receptor (soluble BCMA, or sBCMA) with a human IgG1 Fc domain, to initially test our hypothesis. Next, to enhance the therapeutic efficacy of the approach, we engineered a mutant sBCMA, and developed a …
-
The Relationship Between Barcode Medication Administration Satisfaction and the Use of Workarounds Among Registered Nurses
… implemented barcode medication administration (BCMA) technology for RNs who have accepted this technology with varying levels of satisfaction. When nurses are dissatisfied with a BCMA system, they may find alternative methods to complete their work. Framed by the Technology Acceptance Model …
-
Generation of an antibody targeting B cell maturation antigen for the treatment of multiple myeloma and autoimmune diseases
… directed against the B cell maturation antigen (BCMA). This receptor is important for the expression of anti-apoptotic genes and it is exclusively found on plasma cells and multiple myeloma cells. The anti-BCMA antibody was generated in mice using standard hybridoma technology with subsequent …
-
Analyse des BAFF/APRIL-Systems mit Fokus auf B-Cell Maturation Antigen (BCMA) bei Patientinnen und Patienten mit systemischem Lupus erythematodes
… BAFF und APRIL sowie deren Zielrezeptoren BCMA, TACI und BAFF-Rezeptor, und die Überexpression von Typ-I Interferonen. Diese Faktoren fördern die Aktivierung und das Überleben autoreaktiver B-Zellen, was zur Produktion von Autoantikörpern und Krankheitsaktivität führt. Zudem stellen sie …
-
Long-term toxicity profile for real-world relapsed and refractory multiple myeloma patients treated with anti-BCMA CAR T-cell therapy
… action has led to the development of anti-BCMA CAR T-cell infusions. The overwhelming success of this novel therapy in MM has been demonstrated in clinical trials, but the need for data surrounding the long-term toxicities post-CAR T-cell treatment in a real-world population of MM patients …
-
Evaluation von BAFF-Rezeptor und B-cell maturation Antigen als Targets in der Immuntherapie des Multiplen Myeloms
Bei den Rezeptoren BAFF-R und BCMA handelt es sich um Mitglieder der TNF-Familie, die mit ihrem Liganden BAFF eine wichtige Rolle in der Homöostase und der Entwicklung der B-Zelllinie spielen. Mehrere Autoren zeigten bereits einen Zusammenhang dieses Ligand-/Rezeptorsystems mit der …
-
TAC Engineered γδ T cells for Multiple Myeloma
… with a T cell Antigen Coupler targeting BCMA (BCMA-TAC) for the treatment of Multiple Myeloma – an incurable hematological malignancy. We optimized a manufacturing method to transduce γδ T cells with a GaLV-pseudotyped γ-retrovirus encoding BCMA-TAC and demonstrated that BCMA-TAC γδ T …
-
Professional autonomy and resistance : medical politics in British Columbia, 1964-1993
… of the British Columbia Medical Association (BCMA). Minutes from the BCMA's Board of Directors and Executive, along with interviews with doctors active in BCMA politics, and a media review, are used to generate a portrait of the social forces influencing medical politics in British Columbia …
-
Strategies to Obtain Tumor-Reactive Cells for Cancer Immunotherapy by Cell Sorting and Genetic Modifications of T Lymphocytes
… CARs targeting the B-Cell Maturation Antigen (BCMA). BCMA CAR T cells show antigen-specific cytolytic activity, production of cytokines including IFN-γ and IL-2, as well as productive proliferation. Although we confirm the presence of soluble BCMA in serum of multiple myeloma (MM) patients, we …
-
Increasing Compliance of Bar Code Medication Administration in the Emergency Room
… room (ER). Bar-code medication administration (BCMA) has proven to be effective on the in-patient units in the hospitals researched and visited as part of this project, but the issue still remains that the emergency rooms exhibit a decreased compliance rate. The purpose of this Doctor of Nursing …
-
Knowledge-Based Medication Administration: Program Evaluation and Optimization
… the use of barcoded medication administration (BCMA) systems. While there are many benefits to BCMA, there are also issues with existing systems. Suboptimal BCMA design and implementation has resulted in medication administration workarounds. A hospital located in southern New Hampshire, …
-
Cognitive Task Analysis with Current State Analysis of Medication Administration Process in a Metropolitan Veterans Health Administration Emergency Department
… like barcode medication administration (BCMA) to decrease medication errors and decrease harm to patients. Healthcare organizations committing to zero patient harm would benefit from investing resources to reduce medication errors in the emergency department.Project aims: The purpose of …
Page 1 of 4